Richard Malamut - 10 Feb 2022 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Signature
/s/ Shirley R. Kuhlmann as Attorney-In-Fact For Richard Malamut
Issuer symbol
COLL
Transactions as of
10 Feb 2022
Net transactions value
-$111,069
Form type
4
Filing time
14 Feb 2022, 17:49:23 UTC
Next filing
15 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +36,750 +39% $0.000000 130,308 10 Feb 2022 Direct F1
transaction COLL Common Stock Award +6,256 +4.8% 136,564 10 Feb 2022 Direct F2
transaction COLL Common Stock Tax liability $78,665 -4,462 -3.3% $17.63 132,102 10 Feb 2022 Direct F3
transaction COLL Common Stock Tax liability $32,404 -1,838 -1.4% $17.63 130,264 10 Feb 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
F2 On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 6,256 performance share units granted in the issuer's two prior fiscal years.
F3 Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
F4 Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.